74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Avanos Medical Inc
Closed
SectorHealthcare
12.5 0.64
Overview
Share price change
24h
Min
12.21
Max
12.53
Income | -3.5M 800K |
|---|---|
Sales | 9.2M 180M |
P/E Sector Avg | 33.255 57.333 |
EPS | 0.43 |
Profit margin | 0.445 |
Employees | 2,227 |
EBITDA | -431M -407M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +35.67% upside |
Next Earnings | 6 May 2025 |
|---|
Market Cap | -236M 556M |
|---|---|
Previous open | 11.86 |
Previous close | 12.5 |
Technical Score
By Trading Central
Confidence
Very Strong Bullish Evidence
Avanos Medical Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Avanos Medical Inc Forecast
Price Target
By TipRanks
35.67% upside
12 Months Forecast
Average 17 USD 35.67%
High 17 USD
Low 17 USD
Based on 2 Wall Street analysts offering 12 month price targets forAvanos Medical Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
